what company makes glp 1 GLP-1 Compounding: When Innovation May Mean Liability 2025’s Breakthrough GLP-1 Obesity Treatments:

doi: 10.1111/dom.13494

A growing number of lawsuits are being filed against Novo Nordisk alleging that its GLP-1 receptor agonist drugs, including Ozempic and Wegovy, caused users to suffer permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)

Can my dose be customized based on my weight loss progress

Competitors : Novo Nordisk (Wegovy) and upcoming triple-agonists like Retatrutide Yahoo

I don't really think of it though as like fluoride in the water it's not really meant for public health, and that's why public health has to be a partner with clinical medicine

For the first group, who are eating less but need more from every bite, formulators need to think about hydration, muscle mass maintenance, satiety, digestive support and the sensory issues identified above